Prolonged Course of COVID-19-Associated Pneumonia in a B-Cell Depleted Patient After Rituximab

Patients with pre-existing comorbidities and immunosuppression are at greater risk for SARS-CoV-2 infection and severe manifestations of COVID-19. This also includes cancer patients, who are shown to have a poor prognosis after infection. Here, we describe the case of a 72-year old male patient with...

Descripción completa

Detalles Bibliográficos
Autores principales: Kos, Igor, Balensiefer, Benedikt, Roth, Sophie, Ahlgrimm, Manfred, Sester, Martina, Schmidt, Tina, Thurner, Lorenz, Bewarder, Moritz, Bals, Robert, Lammert, Frank, Stilgenbauer, Stephan, Kaddu-Mulindwa, Dominic
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7493633/
https://www.ncbi.nlm.nih.gov/pubmed/32984017
http://dx.doi.org/10.3389/fonc.2020.01578

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7493633/
https://www.ncbi.nlm.nih.gov/pubmed/32984017
http://dx.doi.org/10.3389/fonc.2020.01578

Ejemplares similares